Skip to content

Clinical trials

Hepatitis trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis Country / region: Canada Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20063
20072
20092
20101
20114
20123
20132
20151
20161
20171
20181
20211
20222
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Terminated3
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences8
Dynavax Technologies Corporation3
GlaxoSmithKline2
Human Genome Sciences Inc.2
Vir Biotechnology, Inc.2
AbbVie1
AusperBio Therapeutics Inc.1
Centre hospitalier de l'Université de Montréal (CHUM)1
F-star Therapeutics, Inc.1
Janssen R&D Ireland1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis27
Hepatitis B13
Hepatitis B, Chronic7
Hepatitis C7
Hepatitis C, Chronic4
Hepatitis, Chronic4
Liver Diseases4
Infections2
Virus Diseases2
Acquired Immunodeficiency Syndrome1

Trials

Showing 26 to 27 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.